From: Multi-omics characterization of a scoring system to quantify hypoxia patterns in patients with head and neck squamous cell carcinoma
Variable
Number of samples
Age at diagnosis (< 60/ ≥ 60)
50/47
Gender(Male/Female)
66/31
Stage(I-II/III-IV)
41/56
HPV16(negative)
97